What is Axsome Therapeutics's gross profit?

Axsome Therapeutics (AXSM) reported gross profit of $176.48M in Q1 2026.

How has Axsome Therapeutics's gross profit changed year-over-year?

Axsome Therapeutics's gross profit increased by 58.0% year-over-year, from $111.67M to $176.48M.

What is the long-term trend for Axsome Therapeutics's gross profit?

Over 3 years (2022 to 2025), Axsome Therapeutics's gross profit has grown at a 136.2% compound annual growth rate (CAGR), from $44.84M to $591.02M.

Axsome Therapeutics AXSM Gross Profit

Gross Profit at other companies

Eli LillyLLY

$16.22B+54.4%

Johnson & JohnsonJNJ

$15.96B+9.8%

AbbVieABBV

$10.78B+15.4%

BiogenBIIB

$1.82B+0.8%

BridgeBio PharmaBBIO

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$191.2M+57.4%

Operating income-$63.4M-11.2%

Net income-$64.5M-8.6%

EPS (diluted)-$1.26-3.3%

Balance sheet

See full

Cash & equivalents$305.1M+1.4%

Total debt$219.9M+4.1%

Total equity$54.6M+2.6%

Total assets$713.6M+19.6%

Cash flow

See full

Operating cash flow-$20.7M+52.3%

CapEx$121.0K-64.2%

Free cash flow-$20.8M+52.4%

Valuation

See full

Market cap$12.89B+52.0%

Enterprise value$12.81B+52.9%

P/S18.2×-1.4×

Profitability

See full

Gross margin92.6%+1.1pp

Operating margin-24.4%-9.3pp

Net margin-26.6%-9.8pp

FCF margin-10.2%-3.9pp

Returns & leverage

See full

Return on equity-349.4%+109pp

Debt / equity4×+0.1×

Current ratio1.4×-0.6×

Where this comes from

Calculated from Axsome Therapeutics’s reported figures.

$191.2Mtotal revenue−$14.7Mtotal cost of revenue=$176.48M

The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axsome Therapeutics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Axsome Therapeutics's gross profit?: Axsome Therapeutics (AXSM) reported gross profit of $176.48M in Q1 2026.
How has Axsome Therapeutics's gross profit changed year-over-year?: Axsome Therapeutics's gross profit increased by 58.0% year-over-year, from $111.67M to $176.48M.
What is the long-term trend for Axsome Therapeutics's gross profit?: Over 3 years (2022 to 2025), Axsome Therapeutics's gross profit has grown at a 136.2% compound annual growth rate (CAGR), from $44.84M to $591.02M.